tetano
Editor, Senior Moderator
Epilepsia. 2020 Apr 18. doi: 10.1111/epi.16524. [Epub ahead of print]
New-onset acute symptomatic seizure and risk factors in Corona Virus Disease 2019: A Retrospective Multicenter Study.
Lu L[SUP]1[/SUP], Xiong W[SUP]1[/SUP], Liu D[SUP]2[/SUP], Liu J[SUP]3[/SUP], Yang D[SUP]3[/SUP], Li N[SUP]4[/SUP], Mu J[SUP]1[/SUP], Guo J[SUP]1[/SUP], Li W[SUP]2[/SUP], Wang G[SUP]2[/SUP], Gao H[SUP]1[/SUP], Zhang Y[SUP]1[/SUP], Lin M[SUP]1[/SUP], Chen L[SUP]1[/SUP], Shen S[SUP]1[/SUP], Zhang H[SUP]1[/SUP], Sander JW[SUP]5,[/SUP][SUP]6[/SUP], Luo J[SUP]7[/SUP], Chen S[SUP]3[/SUP], Zhou D[SUP]1[/SUP].
Author information
Abstract
Our aim was to clarify the incidence and risk of acute symptomatic seizures in people with coronavirus disease 2019 (COVID-19). This multicenter retrospective study enrolled people with COVID-19 from 18 January to 18 February 2020 at 42 government-designated hospitals in Hubei province, the epicenter of the epidemic in China; Sichuan province; and Chongqing municipality. Data were collected from medical records by 11 neurologists using a standard case report form. A total of 304 people were enrolled, of whom 108 had a severe condition. None in this cohort had a known history of epilepsy. Neither acute symptomatic seizures or status epilepticus were observed. Two people had seizure-like symptoms during hospitalization due to acute stress reaction and hypocalcemia, Eighty-four (27%) had brain insults or metabolic imbalances during the disease course known to increase the risk of seizures. There was no evidence suggesting an additional risk of acute symptomatic seizures in people with COVID-19.Neither the virus or potential risk factors for seizures seem to be significant risks for the occurrence of acute symptomatic seizures in COVID-19.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; Epilepsy; SARS-CoV-2; acute symptomatic seizures
PMID:32304092DOI:10.1111/epi.16524
New-onset acute symptomatic seizure and risk factors in Corona Virus Disease 2019: A Retrospective Multicenter Study.
Lu L[SUP]1[/SUP], Xiong W[SUP]1[/SUP], Liu D[SUP]2[/SUP], Liu J[SUP]3[/SUP], Yang D[SUP]3[/SUP], Li N[SUP]4[/SUP], Mu J[SUP]1[/SUP], Guo J[SUP]1[/SUP], Li W[SUP]2[/SUP], Wang G[SUP]2[/SUP], Gao H[SUP]1[/SUP], Zhang Y[SUP]1[/SUP], Lin M[SUP]1[/SUP], Chen L[SUP]1[/SUP], Shen S[SUP]1[/SUP], Zhang H[SUP]1[/SUP], Sander JW[SUP]5,[/SUP][SUP]6[/SUP], Luo J[SUP]7[/SUP], Chen S[SUP]3[/SUP], Zhou D[SUP]1[/SUP].
Author information
Abstract
Our aim was to clarify the incidence and risk of acute symptomatic seizures in people with coronavirus disease 2019 (COVID-19). This multicenter retrospective study enrolled people with COVID-19 from 18 January to 18 February 2020 at 42 government-designated hospitals in Hubei province, the epicenter of the epidemic in China; Sichuan province; and Chongqing municipality. Data were collected from medical records by 11 neurologists using a standard case report form. A total of 304 people were enrolled, of whom 108 had a severe condition. None in this cohort had a known history of epilepsy. Neither acute symptomatic seizures or status epilepticus were observed. Two people had seizure-like symptoms during hospitalization due to acute stress reaction and hypocalcemia, Eighty-four (27%) had brain insults or metabolic imbalances during the disease course known to increase the risk of seizures. There was no evidence suggesting an additional risk of acute symptomatic seizures in people with COVID-19.Neither the virus or potential risk factors for seizures seem to be significant risks for the occurrence of acute symptomatic seizures in COVID-19.
This article is protected by copyright. All rights reserved.
KEYWORDS:
COVID-19; Epilepsy; SARS-CoV-2; acute symptomatic seizures
PMID:32304092DOI:10.1111/epi.16524